other material
confidence high
sentiment neutral
materiality 0.15
Salarius Pharmaceuticals files prospectus supplement for ATM offering of up to $417,000
Decoy Therapeutics Inc.
- Filed prospectus supplement on March 10, 2025 for at-the-market offering of up to $417,000 of common stock.
- Offering conducted through Ladenburg Thalmann & Co. under existing S-3 registration statement (333-266589).
- Legal opinion from Hogan Lovells US LLP included as Exhibit 5.1.